NASDAQ
Helix BioPharma Corp. (HBPCF) has a eps (diluted) of $0.00 as of Thursday, July 31, 2025. Diluted EPS accounts for all potential shares from stock options and convertible securities, providing a more conservative earnings-per-share measure.
No price data available for this timeframe.